| Identification | Back Directory | [Name]
3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID | [CAS]
115664-39-6 | [Synonyms]
3-Carboxy DetoMidine
Detomidine carboxylic acid
detomidine 3-carboxylic acid
3-(1H-IMidazol-5-ylMethyl)-2-Methylbenzoic Acid
3-(1H-IMIDAZOL-4-YLMETHYL)-2-METHYL-BENZOIC ACID
Benzoic acid, 3-(1H-imidazol-5-ylmethyl)-2-methyl- | [Molecular Formula]
C12H12N2O2 | [MDL Number]
MFCD08668137 | [MOL File]
115664-39-6.mol | [Molecular Weight]
216.24 |
| Chemical Properties | Back Directory | [Boiling point ]
499.6±33.0 °C(Predicted) | [density ]
1.278±0.06 g/cm3(Predicted) | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
3.83±0.10(Predicted) | [color ]
White to Pale Brown |
| Hazard Information | Back Directory | [Chemical Properties]
Off-White Solid | [Uses]
The major metabolite of the drug Detomidine. | [in vivo]
Horse urine is investigated for metabolites following the oral administration of the large animal analgesic sedative Detomidine to two stallions and intravenous administration of [3H]-Detomidine to a mare. Detomidine carboxylic acid and hydroxydetomidine glucuronic acid conjugate are identified in the urine after the oral doses. About half of the radioactivity of [3H]-Detomidine is excreted in the urine in 12 h after the i.v. dose (80 μg/kg). Most of the excretion occurred between 5 and 12 h in contrast to urine output which is highest 2-5 h after the dosing. The major radioactive metabolite in the urine is Detomidine carboxylic acid. Detomidine carboxylic acid comprises more than two thirds of the total metabolites in all the urine fractions collected[1]. |
|
| Company Name: |
J & K SCIENTIFIC LTD.
|
| Telephone: |
18210857532 18210857532 |
| Website: |
https://www.jkchemical.com |
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|